WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Pegcetacoplan

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.

    DOI: 10.1016/s0140-6736(23)01520-9

    Source identity and connection checked by Codex (AI).

  2. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

    DOI: 10.1056/nejmoa2029073

    Source identity and connection checked by Codex (AI).

  3. Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

    DOI: 10.1056/nejmoa2501510

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Fakhouri F
  • Bomback AS
  • Ariceta G
  • Delmas Y
  • Dixon BP
  • Gale DP
  • Greenbaum LA
  • Han SH
  • Isbel N
  • Le Quintrec M
  • Licht C
  • Mastrangelo A
  • Mizuno M
  • Neves de Holanda MI
  • Pickering MC
  • Remuzzi G
  • Van De Kar N
  • Vivarelli M
  • Walker PD
  • Wallace D
  • Zecher D
  • Francois C
  • Deschatelets P
  • Li L
  • Wang Z
  • Abad-Franch L
  • Kinnman N
  • López-Lázaro L
  • Szamosi J
  • Nester CM
  • VALIANT Trial Investigators Group
  • Wong RSM
  • Navarro-Cabrera JR
  • Comia NS
  • Goh YT
  • Idrobo H
  • Kongkabpan D
  • Gómez-Almaguer D
  • Al-Adhami M
  • Ajayi T
  • Alvarenga P
  • Savage J
  • Grossi F
  • Dumagay T
  • Heier JS
  • Lad EM
  • Holz FG
  • Rosenfeld PJ
  • Guymer RH
  • Boyer D
  • Baumal CR
  • Korobelnik JF
  • Slakter JS
  • Waheed NK
  • Metlapally R
  • Pearce I
  • Steinle N
  • Francone AA
  • Hu A
  • Lally DR
  • Bliss C
  • Staurenghi G
  • Monés J
  • Singh RP
  • Ribeiro R
  • Wykoff CC
  • OAKS and DERBY study investigators
  • Hillmen P
  • Szer J
  • Weitz I
  • Röth A
  • Höchsmann B
  • Panse J
  • Usuki K
  • Griffin M
  • Kiladjian JJ
  • de Castro C
  • Nishimori H
  • Tan L
  • Hamdani M
  • Risitano A
  • Peffault de Latour R